INDRAMEDCO vs NH: Stock Comparison

INDRAPRASTHA MEDICAL CORP vs NARAYANA HRUDAYALAYAUpdated 11 Sept 26, 4:08 PM ISTNSE & company filings

NARAYANA HRUDAYALAYA is the larger company by market capitalisation. INDRAPRASTHA MEDICAL CORP shows a lower P/E, a higher ROE and a higher dividend yield, while NARAYANA HRUDAYALAYA shows faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

INDRAMEDCO leads 10; NH leads 3 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

INDRAMEDCONH

Valuation lens

What price are you paying?

Market CapContext only
₹3,246 Cr
₹38,215 Cr
P/E RatioINDRAMEDCO has the lower reading
17.26x
46.82x
P/B RatioINDRAMEDCO has the lower reading
4.38x
8.42x
EPSNH has the higher reading
₹6.09
₹6.75
Book ValueContext only
₹80.76
₹222.13
Dividend YieldINDRAMEDCO has the higher reading
1.27%
0.24%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
NH is the larger company
₹38,215 Cr vs ₹3,246 Cr
P/E Ratio
INDRAMEDCO has a lower P/E
17.26x vs 46.82x
P/B Ratio
INDRAMEDCO has a lower P/B
4.38x vs 8.42x
EPS
NH has higher earnings per share
₹6.75 vs ₹6.09
Dividend Yield
INDRAMEDCO has a higher dividend yield
1.27% vs 0.24%
Revenue Growth (TTM YoY)
NH has faster revenue growth
75.8% vs 9.3%
EPS Growth (TTM YoY)
NH has faster EPS growth
13.5% vs 1.8%
Qtr Sales Growth
INDRAMEDCO has stronger quarterly sales growth
11.33% vs -59.12%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricINDRAMEDCONH
SectorHealthcareHealthcare
IndustryHospitalHospital

Price

MetricINDRAMEDCONH
Live Price₹355₹1,869.2
Day Change-1.39%-2.12%
Volume1.85 L1.83 L
52-Week High₹640.85₹2,093.3
52-Week Low₹342₹1,589
Distance from 52W High-44.6%-10.71%

Valuation

MetricINDRAMEDCONH
Market Cap₹3,246 Cr₹38,215 Cr
P/E Ratio17.26x46.82x
P/B Ratio4.38x8.42x
EPS₹6.09₹6.75
Book Value₹80.76₹222.13
Dividend Yield1.27%0.24%

Growth

MetricINDRAMEDCONH
Revenue Growth (TTM YoY)9.3%75.8%
EPS Growth (TTM YoY)1.8%13.5%
Qtr Sales Growth11.33%-59.12%
Qtr Profit Growth33.93%-33.49%

Profitability & Leverage

MetricINDRAMEDCONH
ROE24.8%17.85%
ROCE25.98%11.81%
Net Margin12.21%10.2%
Operating Margin17%15.43%
Debt to Equity0x1.07x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricINDRAMEDCONH
Promoter Holding49.39%63.27%
FII Holding2.77% 0.33 pp9.4% 0.58 pp
DII Holding0.59% 0.29 pp9.06% 0.09 pp
Public Holding45.64% 0.05 pp17.65% 0.67 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: INDRAPRASTHA MEDICAL CORP and NARAYANA HRUDAYALAYA.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.